A rare case of malignant pediatric ectomesenchymoma arising from the falx cerebri

Dana L Altenburger1, Aaron S Wagner, Don E Eslin

  • 1Department of Pathology, Orlando Health, 83 West Columbia Street, Orlando, FL 32806, USA.

Insights

This report details a rare intracranial malignant ectomesenchymoma in a pediatric patient. Complete surgical resection and adjuvant therapy led to a favorable outcome with no recurrence at 20 months.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Rare Tumors

Background:

  • Malignant ectomesenchymoma is an exceptionally rare tumor with limited reported pediatric intracranial cases.
  • This tumor type originates from mature ganglion cells and immature myogenous elements.

Purpose of the Study:

  • To report a rare case of intracranial malignant ectomesenchymoma in a pediatric patient.
  • To describe the clinical presentation, diagnostic findings, and treatment of this rare dural-based tumor.

Main Methods:

  • Case presentation of a 10-year-old boy with an intracranial mass.
  • Diagnostic imaging (CT scan) and extensive immunohistochemical analysis.
  • Surgical resection followed by sarcoma-based chemotherapy and craniospinal axis radiation.

Main Results:

  • A 7.2 × 3.8-cm dural-based mass originating from the falx cerebri was identified.
  • Immunohistochemistry revealed biphenotypic differentiation with markers for smooth muscle, neural, and mesenchymal elements.
  • The patient achieved complete resection and showed no evidence of recurrence or metastasis at 20 months post-treatment.

Conclusions:

  • Intracranial malignant ectomesenchymoma is a rare but treatable pediatric tumor.
  • Multimodal treatment including surgery, chemotherapy, and radiation can lead to favorable outcomes.
  • This case highlights the importance of comprehensive pathological and immunohistochemical evaluation for accurate diagnosis and management.